Opus Genetics, Inc. (IRD) NASDAQ

3.64

+0.25(+7.37%)

Updated at February 13 04:00PM

Currency In USD

Valuation

Market Cap31.79M
Enterprise Value1.47M
P/E Ratio-3.77
PEG Ratio-1.66
Price/Sales Ratio17.16
Price/Book Ratio43.09
Enterprise/Revenue15.12
Enterprise/EBITDA-5.13

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-4.66
Operating Margin-4.45

Management Effectiveness

Return On Assets-1.89
Return On Equity-7.74

Income Statement

Revenue10.99M
Revenue/Share0.21
Gross Profit10.99M
EBITDA-57.52M
Net Income-57.53M
Diluted EPS-2.15

Balance Sheet

Total Cash30.82M
Total Cash/Share0.44
Total Debt1.07M
Total Debt/Equity0.18
Current Ratio1.23
Book Value Per Share0.08

Price History

52-Week Change230.91
52-Week High3.7
52-Week Low0.65
Moving Average 50 Days2.37
Moving Average 200 Days1.63

Statistics

Average Volume690,793
Shares Outstanding68.96M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateNovember 06, 2020